GSK 2194069
Modify Date: 2025-08-25 08:03:02
GSK 2194069 structure
|
Common Name | GSK 2194069 | ||
|---|---|---|---|---|
| CAS Number | 1332331-08-4 | Molecular Weight | 428.48300 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C25H24N4O3 | Melting Point | N/A | |
| MSDS | Chinese USA | Flash Point | N/A | |
| Symbol |
GHS06 |
Signal Word | Danger | |
Use of GSK 2194069GSK2194069 is a potent and specific inhibitor of the β-ketoacyl reductase (KR) activity of hFAS with an IC50 of 7.7 ± 4.1 nM in an assay detecting released CoA.IC50 value: Target: hFAS inhibitor |
| Name | 4-[4-(1-benzofuran-5-yl)phenyl]-5-{[(3S)-1-(cyclopropylcarbonyl)-3-pyrrolidinyl]methyl}-2,4-dihydro-3H-1,2,4-triazol-3-one |
|---|---|
| Synonym | More Synonyms |
| Description | GSK2194069 is a potent and specific inhibitor of the β-ketoacyl reductase (KR) activity of hFAS with an IC50 of 7.7 ± 4.1 nM in an assay detecting released CoA.IC50 value: Target: hFAS inhibitor |
|---|---|
| Related Catalog | |
| References |
| Molecular Formula | C25H24N4O3 |
|---|---|
| Molecular Weight | 428.48300 |
| Exact Mass | 428.18500 |
| PSA | 84.13000 |
| LogP | 3.71270 |
| Storage condition | 2-8℃ |
| Symbol |
GHS06 |
|---|---|
| Signal Word | Danger |
| Hazard Statements | H301 |
| Precautionary Statements | P301 + P310 + P330 |
| RIDADR | UN 2811 6.1 / PGIII |
| gsk2194069 |